lonidamine has been researched along with Rectal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Codacci Pisanelli, G; Franchi, F; Giovagnorio, F; Gualdi, G; Guazzugli Bonaiuti, VP; Seminara, P | 1 |
1 other study(ies) available for lonidamine and Rectal Neoplasms
Article | Year |
---|---|
Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow transplantation in the treatment of advanced colorectal cancer: results from a pilot study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Indazoles; Male; Middle Aged; Mitomycin; Pilot Projects; Rectal Neoplasms; Survival Analysis | 1994 |